Exagen Capital Expenditures (CapEx) Growth & History (XGN)

Exagen's capital expenditures (capex) was $641,000 for fiscal 2025.

View full Exagen company overview

Exagen annual capital expenditures (capex) history

Exagen annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$641,000$126,000+24.47%
20242024-12-31$515,000−$313,000−37.80%
20232023-12-31$828,000−$3.5M−80.82%
20222022-12-31$4.3M$1.9M+82.19%
20212021-12-31$2.4M$1.9M+420.88%
20202020-12-31$455,000$52,000+12.90%
20192019-12-31$403,000$204,000+102.51%
20182018-12-31$199,000

Exagen capital expenditures (capex) trends

Over the last five fiscal years, Exagen's capital expenditures (capex) increased from $455,000 to $641,000, a change of $186,000. The latest reported quarter, Q2 2026, shows $543,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Exagen source filings ↗

Community posts

It’s quiet here.

No posts about XGN yet. Start the conversation.

Write the first post